A molecular analysis of the recurrent tumor via Sanger sequencing using a different IDH2 primer revealed an IDH2 R172W mutation (Figure 1B), and the pathological diagnosis was anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted. This evidence concerns the gene IDH2 and anaplastic oligodendroglioma.